SPIMACO
الدوائيةTechnical Analysis & Signals
The pharmaceutical stock (2070.SR) shows stability in a sideways range with clear support and resistance levels.
Technical Analysis
The stock is currently trading at 30.8 SAR, with an RSI of 52.6 indicating a balance between buying and selling. Additionally, the negative MACD Hist may suggest weakness in upward momentum.
Support & Resistance Levels
The main support level for the stock is 30.65 SAR, while the resistance level is at 32.25 SAR. The stock is expected to trade within this range unless one of these levels is broken.
Volume Analysis
No specific trading volume data is available, but the sideways trend may indicate a decline in activity. An increase in trading volume may be required to confirm any new direction.
Fundamental Factors
The price-to-earnings (P/E) ratio stands at 20.5, indicating a moderate valuation. The dividend yield of 1.13% may attract some investors seeking steady income.
Risk Factors
Potential risks include general market volatility and macroeconomic impacts on the healthcare sector. Any changes in government policies may also affect the stock's performance.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. It is advisable to monitor support and resistance levels before making any investment decisions.
Financial Fundamentals
Price Data
Price Chart - SPIMACO
2070Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 3.68B
- P/E Ratio
- 20.50
- P/B Ratio
- 2.20
- EPS (Earnings/Share)
- 1.50
Profitability
- Revenue
- 1.74B
- Net Income
- 214.39M
- Return on Equity (ROE)
- +12.70%
- Shares Outstanding
- 119.36M
Balance Sheet
- Total Assets
- 4.37B
- Total Debt
- 1.45B
- Debt/Equity
- 0.79
- Free Float %
- +72.5%
Dividends & Margins
- Dividend Yield
- +1.13%
- Dividend/Share
- 0.35
- Book Value
- 14.00
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
5 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2025 | 1.71B +1.5% | 184.36M +651.4% | 4.37B +1.1% | 1.43B -5.2% | 1.54 +633.3% |
| 2024 | 1.68B +1.6% | 24.54M +148.4% | 4.32B +11.3% | 1.51B +35.1% | 0.21 +148.8% |
| 2023 | 1.66B +16.4% | -50.73M +69.3% | 3.88B +1.3% | 1.12B +3.5% | -0.43 +68.8% |
| 2022 | 1.42B | -165.13M | 3.83B | 1.08B | -1.38 |
| 2021 | — | — | — | — | — |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
No news currently available for SPIMACO
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-08-12
Risk Assessment
Risk Factors
Average True Range 2.2% of stock price
Trading volume below 30% of average
P/E ratio 20.5
Debt-to-equity ratio 0.79
ADX indicator at 29
Moderate risk factors with some sector pressures
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is SPIMACO stock price today?
SPIMACO (2070) stock price today is 30.80 SAR, declining by -0.58% compared to the previous session close. The 52-week price range is between 24.65 SAR and 32.71 SAR.
2 What is SPIMACO stock valuation?
The automated analysis signal for SPIMACO is "Hold" with 65% confidence. The P/E ratio is 20.5. The P/B ratio is 2.20.
3 Is SPIMACO Shariah-compliant?
Yes, SPIMACO (2070) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are SPIMACO dividend distributions?
SPIMACO has a dividend yield of 1.13%, with an estimated annual dividend of 0.35 SAR per share.
5 What is SPIMACO weekly performance?
SPIMACO performance over different time periods: weekly change -3.75%, monthly +2.87%, and year-to-date +19.20%. The stock is currently trading with a volume of 188,368 shares.
6 What is the target level for SPIMACO?
According to automated analysis for SPIMACO: Short-term target (1-2 weeks): 31.50 SAR. Medium-term target (1-3 months): 32.00 SAR. Support level: 30.65 SAR. Resistance level: 32.25 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.